エネルギーベースの治療薬市場：製品タイプ、臨床用途、エンドユーザー別-2024-2030年の世界予測

エネルギーベースの治療薬市場規模は2023年に68億米ドルと推計され、2024年には72億8,000万米ドルに達し、CAGR 7.36%で2030年には111億9,000万米ドルに達すると予測されます。

エネルギーベースの治療薬の世界市場

エネルギーベースの治療薬は、医学的状態の診断、管理、治療に様々な形態のエネルギーを利用する多様な医療を指します。これらのエネルギーの応用は、治癒をサポートしたり、痛みを軽減したり、組織構造を変化させたりする生理学的変化をもたらすことを目的としています。エネルギーベースの治療薬には、それぞれ独自の作用機序と適応症を持つ幅広い治療法が含まれています。低侵襲手術に対する需要の増加、がん心血管系疾患の罹患率の上昇、高齢化社会における美容手術の増加が市場の成長を後押ししています。しかし、熟練した専門家の不足や地域によって異なる償還政策が、エネルギーを利用した施術の普及に影響を与える可能性があります。さらに、家庭用エネルギーベース機器の出現と人工知能を備えた機器の統合は、治療成績と患者の安全性を改善するために治療パラメータを最適化することができます。

地域別の洞察

南北アメリカ地域のエネルギーベースの治療薬市場は、強固なヘルスケアインフラ、大規模な研究開発投資、革新的医療技術の高い採用率によって牽引されています。さらに、ブラジルやメキシコをはじめとする国々では、こうした技術を徐々に医療システムに取り入れています。経済格差やヘルスケアインフラの整備状況により、導入ペースは国によって異なります。EMEA（欧州・中東・アフリカ）地域は、医療制度が確立されており、エネルギーベースの治療薬の潜在市場も大きいです。ドイツ、英国、フランス、スイスなどの国々は、強力な研究機関や有利な規制環境を備え、こうした技術の採用の最前線にあります。アラブ首長国連邦（UAE）、サウジアラビア、カタールなどの中東諸国は、ヘルスケア・インフラとテクノロジーへの投資を進めています。アジア太平洋地域、特に中国、日本、インドでは、エネルギーベースの治療薬市場が急成長しています。この成長は、人口の増加、医療ツーリズムの拡大、ヘルスケアインフラの進歩、可処分所得の増加によって推進されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはエネルギーベースの治療薬市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、エネルギーベースの治療薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-エネルギーベースの治療薬市場の市場規模および予測は？

2-エネルギーベースの治療薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-エネルギーベースの治療薬市場における技術動向と規制の枠組みは？

4-エネルギーベースの治療薬市場における主要ベンダーの市場シェアは？

5-エネルギーベースの治療薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で高齢者人口が増加し、それに伴いがんなどの慢性疾患の発生率も増加
    • 従来の手術や治療よりもマイクロ波アブレーションシステムの人気が急増
  • 抑制要因
    • 製品リコールの頻度の増加
  • 機会
    • エネルギーベースの治療薬の技術革新と発展
    • エネルギーベースの治療薬に対する政府の取り組みと有利な償還ポリシー
  • 課題
    • 意識と熟練した人材の不足と治療上の課題
• 市場セグメンテーション分析
  • 製品タイプ：深部病変を治療するための熱および超音波の使用の増加エネルギーベースの治療薬
  • 臨床応用：美容応用におけるエネルギーベースの治療薬の採用
  • エンドユーザー：エネルギーベースの治療薬の専門クリニックの出現
• 市場動向分析
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み

第6章 エネルギーベースの治療薬市場：製品タイプ別

• 凍結療法
• ハイドロメカニカル
• 電子レンジ
• 無線周波数
• 熱と超音波

第7章 エネルギーベースの治療薬市場臨床応用別

• 美的
• 外科および眼科

第8章 エネルギーベースの治療薬市場：エンドユーザー別

• クリニック
• 病院

第9章 南北アメリカのエネルギーベースの治療薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のエネルギーベースの治療薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのエネルギーベースの治療薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ主要企業別の分析
  • 新製品発売と機能強化
  • 受賞・表彰・拡大

第13章 競争力のあるポートフォリオ

• 主要な企業プロファイル
  • Alcon Vision LLC
  • Alna-Medicalsystem AG
  • AngioDynamics
  • AtriCure, Inc.
  • BIOLASE, Inc.
  • Biolitec AG
  • Boston Scientific Corporation
  • Bovie Medical Corporation
  • Candela Corporation by Syneron Medical Ltd.
  • Cutera, Inc.
  • Cynosure Inc.
  • Dornier MedTech GmbH
  • EDAP TMS S.A.
  • Ellex Medical Lasers
  • InSightec Ltd.
  • IRIDEX Corporation
  • Johnson and Johnson Vision Care Inc
  • LightMed Corporation
  • Lumenis Ltd.
  • Medtronic plc
  • NIDEk CO. LTD
  • Optos plc
  • PhotoMedex, Inc.
  • Symmetry Surgical Inc.
  • Ziemer Ophthalmic Systems AG
• 主要な製品ポートフォリオ

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. ENERGY-BASED THERAPEUTICS MARKET RESEARCH PROCESS
• FIGURE 2. ENERGY-BASED THERAPEUTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ENERGY-BASED THERAPEUTICS MARKET DYNAMICS
• FIGURE 7. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 8. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 12. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 22. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ENERGY-BASED THERAPEUTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ENERGY-BASED THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 6. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HYDRO-MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY MICROWAVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY RADIOFREQUENCY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY THERMAL & ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY AESTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY SURGICAL & OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. ENERGY-BASED THERAPEUTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY CLINICAL APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ENERGY-BASED THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. ENERGY-BASED THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 145. ENERGY-BASED THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. ENERGY-BASED THERAPEUTICS MARKET LICENSE & PRICING

[182 Pages Report] The Energy-Based Therapeutics Market size was estimated at USD 6.80 billion in 2023 and expected to reach USD 7.28 billion in 2024, at a CAGR 7.36% to reach USD 11.19 billion by 2030.

Global Energy-Based Therapeutics Market

Energy-based therapeutics refer to a diverse spectrum of medical treatments that utilize various forms of energy to diagnose, manage, or treat medical conditions. The application of these energies aims to bring about physiological changes that can support healing, reduce pain, or alter tissue structures. Energy-based therapeutics encompasses a broad range of modalities, each with unique mechanisms of action and indications. Increasing demand for minimally invasive procedures, higher incidence of cancer cardiovascular diseases, and an increase in cosmetic procedures among the aging population bolster the market's growth. However, a lack of skilled professionals and varied reimbursement policies across different regions can affect the uptake of energy-based procedures. Furthermore, the emergence of home-use energy-based devices and the integration of devices with artificial intelligence can optimize treatment parameters for improved outcomes and patient safety.

Regional Insights

The energy-based therapeutics market in the Americas region is driven by robust healthcare infrastructure, significant R&D investments, and a high adoption rate for innovative medical technologies. Moreover, countries including Brazil and Mexico are gradually incorporating these technologies into their healthcare systems. The pace of adoption varies across different countries due to economic disparities and healthcare infrastructure development. The EMEA region has a well-established healthcare system and significant market potential for energy-based therapeutics. Countries including Germany, the UK, France, and Switzerland are at the forefront of adopting these technologies, with strong research institutions and a favorable regulatory environment. Countries in the Middle East, such as the United Arab Emirates (UAE), Saudi Arabia, and Qatar, are investing in healthcare infrastructure and technology. The Asia Pacific region, particularly China, Japan, and India, is experiencing rapid growth in the energy-based therapeutics market. This growth is propelled by the increasing population, growing medical tourism, advancements in healthcare infrastructure, and rising disposable incomes.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Energy-Based Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Energy-Based Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Energy-Based Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Alna-Medicalsystem AG, AngioDynamics, AtriCure, Inc., BIOLASE, Inc., Biolitec AG, Boston Scientific Corporation, Bovie Medical Corporation, Candela Corporation by Syneron Medical Ltd., Cutera, Inc., Cynosure Inc., Dornier MedTech GmbH, EDAP TMS S.A., Ellex Medical Lasers, InSightec Ltd., IRIDEX Corporation, Johnson and Johnson Vision Care Inc, LightMed Corporation, Lumenis Ltd., Medtronic plc, NIDEk CO. LTD, Optos plc, PhotoMedex, Inc., Symmetry Surgical Inc., and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Energy-Based Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product Type
  • Cryotherapy
  • Hydro-Mechanical
  • Microwave
  • Radiofrequency
  • Thermal & Ultrasound
• Clinical Application
  • Aesthetic
  • Surgical & Ophthalmic
• End-User
  • Clinics
  • Hospital
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Energy-Based Therapeutics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Energy-Based Therapeutics Market?

3. What are the technology trends and regulatory frameworks in the Energy-Based Therapeutics Market?

4. What is the market share of the leading vendors in the Energy-Based Therapeutics Market?

5. Which modes and strategic moves are suitable for entering the Energy-Based Therapeutics Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Energy-Based Therapeutics Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. The increasing geriatric population across the world, coupled with rising incidences of chronic diseases such as cancer
    • 5.1.1.2. The surge in popularity of microwave ablation systems over conventional surgeries and treatment
  • 5.1.2. Restraints
    • 5.1.2.1. Increasing frequency of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovations and developments in energy-based therapeutics
    • 5.1.3.2. Government initiatives and favorable reimbursement policies for energy-based therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. The dearth of awareness and skilled manpower and therapeutic challenges
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Growing use of thermal & ultrasound energy-based therapeutics to treat deep-seated lesions
  • 5.2.2. Clinical Application: Adoption of energy-based therapeutics in aesthetic application
  • 5.2.3. End-User: Emergence of a specialized clinic for energy-based therapeutics
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Energy-Based Therapeutics Market, by Product Type

• 6.1. Introduction
• 6.2. Cryotherapy
• 6.3. Hydro-Mechanical
• 6.4. Microwave
• 6.5. Radiofrequency
• 6.6. Thermal & Ultrasound

7. Energy-Based Therapeutics Market, by Clinical Application

• 7.1. Introduction
• 7.2. Aesthetic
• 7.3. Surgical & Ophthalmic

8. Energy-Based Therapeutics Market, by End-User

• 8.1. Introduction
• 8.2. Clinics
• 8.3. Hospital

9. Americas Energy-Based Therapeutics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Energy-Based Therapeutics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Energy-Based Therapeutics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player
  • 12.3.1. New Product Launch & Enhancement
    • 12.3.1.1. Oculus launches IPL, Radiofrequency Therapy Devices
  • 12.3.2. Award, Recognition, & Expansion
    • 12.3.2.1. Baird Medical's Microwave Ablation System Gains FDA 510(k) Clearance
    • 12.3.2.2. Emblation Launches Swift Microwave Therapy in the Middle East

13. Competitive Portfolio

• 13.1. Key Company Profiles
  • 13.1.1. Alcon Vision LLC
  • 13.1.2. Alna-Medicalsystem AG
  • 13.1.3. AngioDynamics
  • 13.1.4. AtriCure, Inc.
  • 13.1.5. BIOLASE, Inc.
  • 13.1.6. Biolitec AG
  • 13.1.7. Boston Scientific Corporation
  • 13.1.8. Bovie Medical Corporation
  • 13.1.9. Candela Corporation by Syneron Medical Ltd.
  • 13.1.10. Cutera, Inc.
  • 13.1.11. Cynosure Inc.
  • 13.1.12. Dornier MedTech GmbH
  • 13.1.13. EDAP TMS S.A.
  • 13.1.14. Ellex Medical Lasers
  • 13.1.15. InSightec Ltd.
  • 13.1.16. IRIDEX Corporation
  • 13.1.17. Johnson and Johnson Vision Care Inc
  • 13.1.18. LightMed Corporation
  • 13.1.19. Lumenis Ltd.
  • 13.1.20. Medtronic plc
  • 13.1.21. NIDEk CO. LTD
  • 13.1.22. Optos plc
  • 13.1.23. PhotoMedex, Inc.
  • 13.1.24. Symmetry Surgical Inc.
  • 13.1.25. Ziemer Ophthalmic Systems AG
• 13.2. Key Product Portfolio

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing